WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
ICLR
ICON PLC
$26.02B7.50%4.00%7.31%20.70%0.811.2129.60%8.30%12.52%
STRR
STAR EQUITY HOLDINGS INC
$13.95M42.40%31.80%35.27%72.30%0.163.9926.00%50.70%51.43%
FONR
FONAR CORP
$102.27M6.30%5.10%8.55%10.00%0.329.3745.50%10.00%16.24%
TMO
THERMO FISHER SCIENTIFIC INC
$227.24B13.30%6.20%9.61%15.50%1.131.7040.40%14.20%18.81%
IDXX
IDEXX LABORATORIES INC
$44.88B63.70%27.60%46.96%45.20%1.141.5760.10%23.30%30.21%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$11.42B12.70%5.50%9.45%11.60%1.221.7535.70%10.70%16.54%
ENZ
ENZO BIOCHEM INC
$55.84M53.70%32.60%43.30%151.90%0.403.20112.30%254.30%249.49%
DGX
QUEST DIAGNOSTICS INC
$16.03B13.30%6.20%10.77%16.40%1.160.9732.90%9.10%13.51%
MEDP
MEDPACE HOLDINGS INC
$12.19B59.70%19.70%42.66%-710.00%1.670.7828.00%15.90%18.24%
SHC
SOTERA HEALTH CO
$3.20B13.10%1.80%9.20%7.80%6.133.2055.00%5.10%24.83%
NEOG
NEOGEN CORP
$2.93B0.00%0.00%1.64%5.10%0.463.8251.00%0.20%7.80%
LAB
STANDARD BIOTOOLS INC
$956.40M-295.40%-30.30%-13.14%-41.30%0.354.5149.10%-107.30%-68.00%
A
AGILENT TECHNOLOGIES INC
$45.20B21.20%11.50%15.26%24.30%0.772.6850.60%18.40%21.14%
QGEN
QIAGEN NV
$10.23B9.20%5.60%9.88%15.00%0.611.8462.80%17.40%24.37%
DHR
DANAHER CORP
$196.87B8.30%5.20%7.07%19.20%0.561.8558.40%19.50%23.73%
FLGT
FULGENT GENETICS INC
$661.63M-13.90%-12.80%-13.86%-17.20%0.095.0937.50%-57.70%-55.62%
SERA
SERA PROGNOSTICS INC
$269.72M-46.40%-36.30%-51.63%-53.80%0.392.1919.90%-16,395.10%-16,371.84%
CSTL
CASTLE BIOSCIENCES INC
$669.20M-7.90%-6.90%-7.18%-14.40%0.149.2680.60%-12.30%-12.22%
EXAS
EXACT SCIENCES CORP
$9.30B-7.70%-3.80%-3.62%-5.70%1.041.6473.70%-9.50%-8.13%
NTRA
NATERA INC
$13.07B-49.70%-26.10%-30.31%-38.70%0.854.1250.30%-30.20%-29.14%
PRE
PRENETICS GLOBAL LTD
$70.84M-28.70%-22.80%-29.34%-80.70%0.212.3740.60%-288.50%-289.72%
RVTY
REVVITY INC
$13.60B1.90%1.10%1.95%4.10%0.712.2355.50%5.50%8.62%
CHEK
CHECK-CAP LTD
$12.78M-59.40%-54.40%-81.42%-87.30%0.0618.69N/AN/AN/A
OLK
OLINK HOLDING AB (PUBL)
$2.98B-7.10%-6.00%-8.22%-25.40%0.185.6066.90%-19.70%-24.22%
LH
LABCORP HOLDINGS INC
$17.75B5.30%2.60%6.53%8.50%1.080.8827.70%3.50%6.69%
WAT
WATERS CORP
$21.11B59.10%13.30%21.74%20.20%2.591.9459.70%20.70%27.36%
PRPO
PRECIPIO INC
$9.24M-36.20%-26.80%-36.72%-683.40%0.300.7839.10%-31.00%-30.88%
DRIO
DARIOHEALTH CORP
$56.85M-84.80%-52.40%-46.75%-162.30%0.762.9527.60%-314.50%-292.52%
NEO
NEOGENOMICS INC
$1.89B-8.90%-5.00%-5.18%-8.30%0.787.4841.80%-13.80%-13.26%
TWST
TWIST BIOSCIENCE CORP
$2.74B-31.60%-25.40%-30.10%-52.80%0.265.5138.30%-69.20%-68.93%
IQV
IQVIA HOLDINGS INC
$42.12B22.60%5.20%10.60%16.30%3.190.8835.00%9.00%14.15%
MTD
METTLER TOLEDO INTERNATIONAL INC
$32.52B-617.10%23.40%48.63%31.60%-21.691.0759.20%20.50%27.63%
BNR
BURNING ROCK BIOTECH LTD
$85.03M-71.70%-52.80%-83.86%-261.80%0.353.3667.60%-121.60%-121.19%
ACRS
ACLARIS THERAPEUTICS INC
$84.81M-48.60%-37.40%-50.41%-54.90%0.236.7442.00%-248.30%-249.46%
RDNT
RADNET INC
$4.24B3.10%0.80%3.61%3.40%2.171.8613.70%1.30%5.54%
CDNA
CAREDX INC
$807.30M-55.60%-37.90%-51.11%-72.80%0.774.3262.90%-66.60%-71.01%
PSNL
PERSONALIS INC
$72.71M-64.20%-41.30%-56.41%-57.70%0.623.8425.60%-124.90%-124.70%
STIM
NEURONETICS INC
$78.29M-75.80%-26.70%-24.12%-23.60%2.755.6572.90%-37.60%-29.42%
ME
23ANDME HOLDING CO
$283.47M-87.30%-64.80%-112.60%-534.30%0.612.1545.30%-210.50%-210.72%
GH
GUARDANT HEALTH INC
$3.10B-246.50%-25.90%-30.81%-21.40%23.965.9560.40%-76.30%-75.77%
XWEL
XWELL INC
$7.28M-137.00%-55.70%-87.34%-67.40%1.772.6618.30%-77.90%-77.77%
OCX
ONCOCYTE CORP
$39.16M-144.40%-51.90%-64.00%-954.60%4.670.7922.10%-2,956.70%-2,901.01%
MYGN
MYRIAD GENETICS INC
$2.29B-31.70%-20.40%-24.12%-58.00%0.461.9968.80%-30.30%-30.04%
DMTK
DERMTECH INC
$17.45M-138.80%-69.00%-99.09%-68.20%1.583.538.50%-572.20%-572.19%
XGN
EXAGEN INC
$32.66M-75.90%-33.30%-40.65%-41.50%1.544.8358.80%-34.70%-30.65%
PRPH
PROPHASE LABS INC
$95.97M-45.00%-25.90%-46.31%-42.30%1.011.8818.40%-82.20%-106.63%
AWH
ASPIRA WOMEN's HEALTH INC
$33.12MN/A-197.80%-788.03%-2,212.20%-6.261.1658.80%-164.00%-163.99%
NDRA
ENDRA LIFE SCIENCES INC
$3.39M-184.20%-138.10%-257.37%-334.10%0.371.04N/AN/AN/A
VNRX
VOLITIONRX LTD
$63.77MN/A-150.20%287.45%278.30%-2.310.43100.00%-4,379.60%-4,348.57%
MDXH
MDXHEALTH SA
$7.86M-314.60%-30.20%-27.74%-27.20%-126.121.6962.80%-53.00%-37.86%
GENE
GENETIC TECHNOLOGIES LTD
$526.30k-160.90%-105.50%-252.20%-5,353.20%0.761.6753.50%-150.00%-149.85%
NOTV
INOTIV INC
$50.12M-28.30%-8.50%-11.64%-6.00%2.940.3728.80%-12.90%-6.79%
BIAF
BIOAFFINITY TECHNOLOGIES INC
$26.35M-132.80%-94.70%-132.12%-374.40%0.532.2232.90%-169.40%-167.97%
MYNZ
MAINZ BIOMED NV
$14.39M-488.00%-145.80%-412.93%-1,525.40%3.740.9756.90%-2,936.50%-2,846.09%
ILMN
ILLUMINA INC
$17.69B-21.50%-12.30%-12.53%-25.10%0.751.7561.40%-28.70%-23.88%
OPK
OPKO HEALTH INC
$920.03M-18.00%-12.30%-13.15%-31.50%0.581.9232.60%-31.60%-29.11%
PMD
PSYCHEMEDICS CORP
$14.98M-60.40%-33.00%-49.90%-37.90%0.781.4838.60%-20.60%-16.10%
APDN
APPLIED DNA SCIENCES INC
$2.47M-305.20%-103.00%-187.22%-781.40%-194.211.6634.00%-226.50%-222.32%
TRIB
TRINITY BIOTECH PLC
$12.11MN/A-33.60%-29.33%-13.10%-3.482.6034.20%-42.30%-22.92%
BDSX
BIODESIX INC
$180.63MN/A-53.70%-66.79%-54.30%-16.850.9176.30%-85.80%-68.16%
MMA
ALTA GLOBAL GROUP LTD
N/AN/AN/A77.57%N/A-0.550.2285.00%-1,340.30%-1,049.23%
ISPC
ISPECIMEN INC
$2.40M-105.30%-74.40%-169.57%-539.00%0.840.9349.60%-124.80%-124.65%
TTOO
T2 BIOSYSTEMS INC
$49.59MN/A-130.50%129.03%-328.50%-1.660.28-117.00%-636.10%-566.42%
CNTG
CENTOGENE NV
$10.21MN/A-42.10%-80.20%-31.30%-4.051.0235.50%-73.80%-55.83%

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 47, which is 21 points higher than the diagnostic & research industry average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 49.4% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 9.42% from Icon's current stock price of $314.72.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second best diagnostic & research stock with a Zen Score of 46, which is 20 points higher than the diagnostic & research industry average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 10% over the past year, underperforming other diagnostic & research stocks by -1 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third best diagnostic & research stock with a Zen Score of 43, which is 17 points higher than the diagnostic & research industry average of 26. It passed 13 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock lose -9.98% over the past year, underperforming other diagnostic & research stocks by -21 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.8%, which is 2 percentage points higher than the diagnostic & research industry average of 1.25%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2%, which is 1 percentage points higher than the diagnostic & research industry average of 1.25%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Labcorp Holdings (NYSE:LH)


Labcorp Holdings (NYSE:LH) has an annual dividend yield of 1.03%, which is the same as the diagnostic & research industry average of 1.25%. Labcorp Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Labcorp Holdings's dividend has not shown consistent growth over the last 10 years.

Labcorp Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.44% in the last day, and up 1.56% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 10% in the past year. It has underperformed other stocks in the diagnostic & research industry by -1 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -52.81% in the past year. It has underperformed other stocks in the diagnostic & research industry by -64 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has dropped -9.98% in the past year. It has underperformed other stocks in the diagnostic & research industry by -21 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 5.02% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.96x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.